In an editorial in medical journal JAMA, FDA Commissioner Marty Makary and the new director of the Center for Biologics Evaluation and Research (CBER), Vinay Prasad, also said they aim to work ...

The green light in the US is the first worldwide for Enflonsia (clesrovimab) and makes the long-acting antibody the first competitor to Sanofi and AstraZeneca's blockbuster Beyfortus (nirsevimab ...